MEITAV INVESTMENT HOUSE LTD UroGen Pharma Ltd. Transaction History

MEITAV INVESTMENT HOUSE LTD portfolio value:

$1.13M
portfolio value

MEITAV INVESTMENT HOUSE LTD quarter portfolio value change:

+1.59%
quarter

UroGen Pharma Ltd. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 12K $8.32 136.83K
Q2 2022 share 0.00% 0 shares -71K $8.19 136.83K
Q1 2022 share Decrease -12.39% -19.35K shares -303K $8.71 136.83K
Q4 2021 share Increase +23.38% 29.59K shares -634K $9.9 156.18K
Q3 2021 share Increase +25.94% 26.07K shares 594K $16.82 126.59K
Q2 2021 share Increase +58.85% 37.23K shares 302K $15.27 100.51K
Q1 2021 share Increase 0.00% 63.28K shares 1.23M $19.48 63.28K
Q4 2020 share Decrease -100.00% -48.40K shares -934K $18.02 0
Q3 2020 share Increase +11.91% 5.15K shares -194K $19.29 48.40K
Q2 2020 share Increase +42.26% 12.84K shares 584K $26.12 43.25K
Q1 2020 share Decrease -88.82% -241.65K shares -8.53M $17.84 30.40K
Q4 2019 share Increase +9.44% 23.47K shares 2.77M $33.37 272.06K
Q3 2019 share Decrease -56.04% -316.95K shares -13.99M $23.83 248.59K
Q2 2019 share Decrease -0.05% -300 shares -593K $35.94 565.54K
Q1 2019 share Increase +35.21% 147.35K shares 2.88M $36.94 565.84K
Q4 2018 share Decrease -28.35% -165.61K shares -9.77M $43.06 418.49K
Q3 2018 share Increase +14.68% 74.74K shares -2.16M $47.23 584.10K
Q2 2018 share Increase +13.86% 62.00K shares 7.73M $49.76 509.35K
Q1 2018 share Increase +8.35% 34.47K shares 6.86M $49.69 447.35K
Q4 2017 share Increase 0.00% 412.88K shares 15.36M $37.21 412.88K